NCT06799884View on ClinicalTrials.gov

A Drug-drug Interaction Trial in Healthy Female Participants to Investigate the Effect of Aprocitentan on Combined Hormonal Contraceptives

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 18, 2025

Primary Completion Date

February 21, 2025

Study Completion Date

February 21, 2025

Conditions
Drug Drug Interaction
Interventions
DRUG

Ethinyl Estradiol / Levonorgestrel Oral Tablet

Coated tablet of 20 µg ethinyl estradiol and 100 µg levonorgestrel

DRUG

Aprocitentan

Film-coated tablet of aprocitentan 25 mg

Trial Locations (1)

323 00

CEPHA s.r.o., Pilsen

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY

NCT06799884 - A Drug-drug Interaction Trial in Healthy Female Participants to Investigate the Effect of Aprocitentan on Combined Hormonal Contraceptives | Biotech Hunter | Biotech Hunter